Canaccord Genuity Maintains a 'Hold' on Dendreon (DNDN) After Meeting with Management

May 23, 2012 8:53 AM EDT Send to a Friend
Get Alerts DNDN Hot Sheet
Price: $1.03 --0%

Rating Summary:
    3 Buy, 18 Hold, 12 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 27 | Down: 26 | New: 17
Trade DNDN Now!
Join SI Premium – FREE
Canaccord Genuity maintains a 'Hold' on Dendreon (NASDAQ: DNDN) price target of $11.00.

Analyst, Salveen Richter, said, "1Q “big accounts” for the first time included community clinics: According to management, ~10 community accounts, consisting of both urology and oncology clinics, have been categorized as “big accounts" (~5 to 6+ patients treated per month). Prior to 1Q, “big accounts” only consisted of academic centers. In addition, in 1Q, the sales team focused on large urology accounts was fully staffed and the PROPEL program (physicians educating patients) was introduced."

For an analyst ratings summary and ratings history on Dendreon click here. For more ratings news on Dendreon click here.

Shares of Dendreon closed at $7.70 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View

Add Your Comment